Activity: Manufactures and markets larvae products for the treatment of chronic infected and necrotic wounds.
Gambit Corporate Finance LLP acted as the lead advisor to ZooBiotic on its acquisition of BioMonde.
Activity: Manufactures and markets larvae products for the treatment of chronic infected and necrotic wounds.
Gambit Corporate Finance LLP acted as the lead advisor to ZooBiotic on its acquisition of BioMonde.
Get in touch with our team of experts to find out how we can support you and your business.
"*" indicates required fields
© 2023 Gambit Corporate Finance LLP is authorised and regulated by the Financial Conduct Authority FRN 520662. The firm is not subject to the requirements of the Stewardship code. Registered Number: OC350202